交易 Edwards Lifesciences - EW CFD
加入收藏夹- 概括
- 历史数据
- 活动
- 收入报表
- 资产负债表
- 现金流
- 所有权
交易条件
价差 | 0.23 | ||||||||
多头隔夜费
Long position overnight fee
前往平台 | -0.024068% | ||||||||
空头隔夜费
Short position overnight fee
前往平台 | 0.001846% | ||||||||
隔夜费时间 | 21:00 (UTC) | ||||||||
最小交易量 | 1 | ||||||||
货币 | USD | ||||||||
保证金 | 20% | ||||||||
上市交易所 | United States of America | ||||||||
交易费 | 0% |
*Information provided by Capital.com
Edwards Lifesciences Corp ESG Risk Ratings
High Medium Low Negligible
‘B’ score indicates good relative ESG performance and above average degree of transparency in reporting material ESG data publicly.
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
Date | 平倉 | Change | Change (%) | 開倉 | High | Low |
---|---|---|---|---|---|---|
Mar 21, 2023 | 81.59 | 0.59 | 0.73% | 81.00 | 82.33 | 80.63 |
Mar 20, 2023 | 80.93 | 0.79 | 0.99% | 80.14 | 81.60 | 79.74 |
Mar 17, 2023 | 80.60 | -0.59 | -0.73% | 81.19 | 82.47 | 80.07 |
Mar 16, 2023 | 81.75 | 3.75 | 4.81% | 78.00 | 82.14 | 77.86 |
Mar 15, 2023 | 79.38 | 2.90 | 3.79% | 76.48 | 79.40 | 76.42 |
Mar 14, 2023 | 78.02 | 0.90 | 1.17% | 77.12 | 78.15 | 76.27 |
Mar 13, 2023 | 76.49 | 3.17 | 4.32% | 73.32 | 76.92 | 73.00 |
Mar 10, 2023 | 74.24 | -1.46 | -1.93% | 75.70 | 75.78 | 73.78 |
Mar 9, 2023 | 75.94 | -1.12 | -1.45% | 77.06 | 78.03 | 75.78 |
Mar 8, 2023 | 77.13 | 0.21 | 0.27% | 76.92 | 77.33 | 75.83 |
Mar 7, 2023 | 78.81 | 0.39 | 0.50% | 78.42 | 79.91 | 78.32 |
Mar 6, 2023 | 78.68 | -1.99 | -2.47% | 80.67 | 81.19 | 78.41 |
Mar 3, 2023 | 81.76 | 0.83 | 1.03% | 80.93 | 82.05 | 80.47 |
Mar 2, 2023 | 80.12 | 1.19 | 1.51% | 78.93 | 80.72 | 78.83 |
Mar 1, 2023 | 79.77 | 0.08 | 0.10% | 79.69 | 79.96 | 78.57 |
Feb 28, 2023 | 80.37 | 3.57 | 4.65% | 76.80 | 80.88 | 76.80 |
Feb 27, 2023 | 77.21 | 0.80 | 1.05% | 76.41 | 78.27 | 76.41 |
Feb 24, 2023 | 76.11 | 0.00 | 0.00% | 76.11 | 77.08 | 75.74 |
Feb 23, 2023 | 77.46 | 2.13 | 2.83% | 75.33 | 77.57 | 75.33 |
Feb 22, 2023 | 75.31 | -0.21 | -0.28% | 75.52 | 76.45 | 75.24 |
Edwards Lifesciences Events
時間(協調世界時) (UTC) | 國家 | 事件 |
---|---|---|
No events scheduled |
- 年度
- 每季度
2021 | 2020 | 2019 | 2018 | 2017 | |
---|---|---|---|---|---|
总收入 | 5232.5 | 4386.3 | 4348 | 3722.8 | 3435.3 |
收入 | 5232.5 | 4386.3 | 4348 | 3722.8 | 3435.3 |
收入成本,共计 | 1248.9 | 1080.6 | 1114.4 | 939.4 | 875.3 |
毛利 | 3983.6 | 3305.7 | 3233.6 | 2783.4 | 2560 |
总营业费用 | 3542.2 | 3488.7 | 3201.2 | 2967.5 | 2400.4 |
销售/一般/行政费用,总计 | 1493.7 | 1228.4 | 1240.2 | 1088.5 | 985.8 |
研究与开发 | 903.1 | 760.7 | 752.7 | 622.2 | 552.6 |
利息费用(收入) - 净运营 | -1.6 | ||||
异常费用(收入) | 20.6 | 405.4 | 100 | 323.1 | -13.4 |
Other Operating Expenses, Total | -124.1 | 13.6 | -6.1 | -5.7 | 1.7 |
营业收入 | 1690.3 | 897.6 | 1146.8 | 755.3 | 1034.9 |
税前净收入 | 1702 | 916.7 | 1166.5 | 761.4 | 1034.9 |
税后净收入 | 1503.1 | 823.4 | 1049.7 | 738 | 877.7 |
未计算非常项目前的净收益 | 1503.1 | 823.4 | 1049.7 | 738 | 877.7 |
净收入 | 1503.1 | 823.4 | 1046.9 | 722.2 | 583.6 |
普通股股东可获收益 (不含非经常性项目) | 1503.1 | 823.4 | 1049.7 | 738 | 877.7 |
普通股股东可获收益 (含非經常性項目) | 1503.1 | 823.4 | 1046.9 | 722.2 | 583.6 |
摊薄净收入 | 1503.1 | 823.4 | 1046.9 | 722.2 | 583.6 |
摊薄后加权平均股 | 631.2 | 631.9 | 636.606 | 640.806 | 647.706 |
扣除特别项目的每股摊薄盈利 | 2.38134 | 1.30305 | 1.6489 | 1.15167 | 1.35509 |
每股正常摊薄盈利 | 2.41016 | 1.87932 | 1.79025 | 1.64039 | 1.33754 |
非常规项目总计 | -2.8 | -15.8 | -294.1 | ||
利息收入(费用),非经营净值 | 9.8 | 20.5 | 21.3 | 17.3 | |
其他,净值 | 1.9 | -1.4 | -1.6 | -11.2 |
Mar 2022 | Dec 2021 | Sep 2021 | Jun 2021 | Mar 2021 | |
---|---|---|---|---|---|
总收入 | 1341.2 | 1329.7 | 1310.2 | 1376 | 1216.6 |
收入 | 1341.2 | 1329.7 | 1310.2 | 1376 | 1216.6 |
收入成本,共计 | 299.3 | 309.5 | 311.7 | 334.3 | 293.4 |
毛利 | 1041.9 | 1020.2 | 998.5 | 1041.7 | 923.2 |
总营业费用 | 902.4 | 955.3 | 919.9 | 833.9 | 833.1 |
销售/一般/行政费用,总计 | 370.3 | 424 | 364.4 | 374.5 | 330.8 |
研究与开发 | 228.6 | 232.8 | 238 | 225.3 | 207 |
异常费用(收入) | 7.1 | 7.1 | 4.7 | 2.4 | 6.4 |
Other Operating Expenses, Total | -2.9 | -18.1 | 1.1 | -102.6 | -4.5 |
营业收入 | 438.8 | 374.4 | 390.3 | 542.1 | 383.5 |
利息收入(费用),非经营净值 | -4 | 1.6 | 0.4 | 3.1 | 4.7 |
其他,净值 | 1.3 | 0.3 | 0.2 | 0.3 | 1.1 |
税前净收入 | 436.1 | 376.3 | 390.9 | 545.5 | 389.3 |
税后净收入 | 373.6 | 335.3 | 340.1 | 489.5 | 338.2 |
未计算非常项目前的净收益 | 373.6 | 335.3 | 340.1 | 489.5 | 338.2 |
净收入 | 373.6 | 335.3 | 340.1 | 489.5 | 338.2 |
普通股股东可获收益 (不含非经常性项目) | 373.6 | 335.3 | 340.1 | 489.5 | 338.2 |
普通股股东可获收益 (含非經常性項目) | 373.6 | 335.3 | 340.1 | 489.5 | 338.2 |
摊薄净收入 | 373.6 | 335.3 | 340.1 | 489.5 | 338.2 |
摊薄后加权平均股 | 629.4 | 631.8 | 631.7 | 629.9 | 631.3 |
扣除特别项目的每股摊薄盈利 | 0.59358 | 0.53071 | 0.53839 | 0.77711 | 0.53572 |
Dividends per Share - Common Stock Primary Issue | 0 | 0 | 0 | 0 | |
每股正常摊薄盈利 | 0.60325 | 0.54072 | 0.54486 | 0.78053 | 0.54453 |
- 年度
- 每季度
2021 | 2020 | 2019 | 2018 | 2017 | |
---|---|---|---|---|---|
流动资产总额 | 3180.7 | 3091 | 2984 | 2286.9 | 2549.2 |
现金和短期投资 | 1466.8 | 1402.6 | 1516.9 | 956.5 | 1337.5 |
现金等价物 | 862.8 | 1183.2 | 1179.1 | 714.1 | 818.3 |
短期投资 | 604 | 219.4 | 337.8 | 242.4 | 519.2 |
应收账款总额,净额 | 664.9 | 602.8 | 599.1 | 537.3 | 479.3 |
Accounts Receivable - Trade, Net | 582.2 | 514.6 | 543.6 | 456.9 | 438.7 |
Total Inventory | 726.7 | 802.3 | 640.9 | 607 | 554.9 |
Prepaid Expenses | 85.2 | 75.1 | 59.1 | 54.3 | 60.6 |
Other Current Assets, Total | 237.1 | 208.2 | 168 | 131.8 | 116.9 |
Total Assets | 8502.6 | 7237.1 | 6488.1 | 5323.7 | 5666.4 |
Property/Plant/Equipment, Total - Net | 1638.7 | 1489.4 | 1140.4 | 867.5 | 679.7 |
Goodwill, Net | 1167.9 | 1173.2 | 1167.7 | 1112.2 | 1126.5 |
Intangibles, Net | 323.6 | 331.4 | 336.5 | 343.2 | 468 |
Long Term Investments | 1834.2 | 801.6 | 585.5 | 506.3 | 567 |
Other Long Term Assets, Total | 357.5 | 350.5 | 274 | 207.6 | 276 |
Total Current Liabilities | 1032.3 | 893.9 | 902.4 | 876.6 | 1420 |
Accounts Payable | 204.5 | 196.5 | 180.4 | 134 | 116.6 |
Accrued Expenses | 714.2 | 578.7 | 642.7 | 510.2 | 516.1 |
Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities, Total | 113.6 | 118.7 | 79.3 | 232.4 | 189.3 |
Total Liabilities | 2666.7 | 2662.8 | 2339.8 | 2183.3 | 2710.2 |
Total Long Term Debt | 595.7 | 595 | 594.4 | 593.8 | 438.4 |
Long Term Debt | 595.7 | 595 | 594.4 | 593.8 | 438.4 |
Other Liabilities, Total | 779.7 | 959.5 | 671.3 | 588 | 851.8 |
Total Equity | 5835.9 | 4574.3 | 4148.3 | 3140.4 | 2956.2 |
Preferred Stock - Non Redeemable, Net | 0 | 0 | 0 | 0 | 0 |
Common Stock | 642 | 636.4 | 218.1 | 215.2 | 212 |
Additional Paid-In Capital | 1700.4 | 1438.1 | 1623.3 | 1384.4 | 1166.9 |
Retained Earnings (Accumulated Deficit) | 6068.1 | 4565 | 3741.6 | 2694.7 | 1962.1 |
Treasury Stock - Common | -2416.9 | -1904.1 | -1278.7 | -1015.4 | -252.1 |
Other Equity, Total | -150.8 | -169.7 | -157.7 | -133.5 | -128.1 |
Total Liabilities & Shareholders’ Equity | 8502.6 | 7237.1 | 6488.1 | 5323.7 | 5666.4 |
Total Common Shares Outstanding | 624.1 | 624.3 | 627.306 | 623.106 | 629.106 |
Current Port. of LT Debt/Capital Leases | 0 | 0 | 0 | 598 | |
Unrealized Gain (Loss) | -6.9 | 8.6 | 1.7 | -5 | -4.6 |
Property/Plant/Equipment, Total - Gross | 2293.3 | 2087.9 | 1652.7 | 1322.8 | |
Accumulated Depreciation, Total | -654.6 | -598.5 | -512.3 | -455.3 | |
Deferred Income Tax | 259 | 214.4 | 171.7 | 124.9 |
Mar 2022 | Dec 2021 | Sep 2021 | Jun 2021 | Mar 2021 | |
---|---|---|---|---|---|
流动资产总额 | 3241.3 | 3180.7 | 3515.5 | 3322.9 | 3069.2 |
现金和短期投资 | 1495.9 | 1466.8 | 1794.7 | 1561.2 | 1330.6 |
现金等价物 | 1030.9 | 862.8 | 1506.9 | 1312.8 | 1174.2 |
短期投资 | 465 | 604 | 287.8 | 248.4 | 156.4 |
应收账款总额,净额 | 686.2 | 664.9 | 664.2 | 700.3 | 664.3 |
Accounts Receivable - Trade, Net | 636.3 | 582.2 | 600.6 | 640.5 | 586.6 |
Total Inventory | 730.6 | 726.7 | 737.8 | 759.5 | 767.9 |
Prepaid Expenses | 94.1 | 85.2 | 76.9 | 68.6 | 77.3 |
Other Current Assets, Total | 234.5 | 237.1 | 241.9 | 233.3 | 229.1 |
Total Assets | 8419.9 | 8502.6 | 8160.3 | 7662.1 | 7213.7 |
Property/Plant/Equipment, Total - Net | 1642.3 | 1638.7 | 1549.4 | 1530.4 | 1506.4 |
Goodwill, Net | 1166.3 | 1167.9 | 1170.4 | 1171.8 | 1170.8 |
Intangibles, Net | 322 | 323.6 | 325.3 | 327 | 330.3 |
Long Term Investments | 1623.7 | 1834.2 | 1282 | 1014.2 | 802.2 |
Other Long Term Assets, Total | 424.3 | 357.5 | 317.7 | 295.8 | 334.8 |
Total Current Liabilities | 949.9 | 1032.3 | 966.5 | 886.2 | 799 |
Accounts Payable | 158.8 | 204.5 | 139.5 | 144.6 | 150.4 |
Accrued Expenses | 615.9 | 714.2 | 721.7 | 634.7 | 546.9 |
Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities, Total | 175.2 | 113.6 | 105.3 | 106.9 | 101.7 |
Total Liabilities | 2575 | 2666.7 | 2619 | 2528.8 | 2555.3 |
Total Long Term Debt | 595.9 | 595.7 | 595.5 | 595.4 | 595.2 |
Long Term Debt | 595.9 | 595.7 | 595.5 | 595.4 | 595.2 |
Deferred Income Tax | 270.7 | 259 | 245.4 | 234.2 | 224.2 |
Other Liabilities, Total | 758.5 | 779.7 | 811.6 | 813 | 936.9 |
Total Equity | 5844.9 | 5835.9 | 5541.3 | 5133.3 | 4658.4 |
Preferred Stock - Non Redeemable, Net | 0 | 0 | 0 | 0 | 0 |
Common Stock | 642.9 | 642 | 641.2 | 640.1 | 637.5 |
Additional Paid-In Capital | 1769.4 | 1700.4 | 1643.1 | 1578.7 | 1496.8 |
Retained Earnings (Accumulated Deficit) | 6441.7 | 6068.1 | 5732.8 | 5392.7 | 4903.2 |
Treasury Stock - Common | -2822.5 | -2416.9 | -2320.4 | -2318.6 | -2206.7 |
Unrealized Gain (Loss) | -39.2 | -6.9 | 3 | 4.8 | 4.7 |
Other Equity, Total | -147.4 | -150.8 | -158.4 | -164.4 | -177.1 |
Total Liabilities & Shareholders’ Equity | 8419.9 | 8502.6 | 8160.3 | 7662.1 | 7213.7 |
Total Common Shares Outstanding | 621.4 | 624.1 | 624.2 | 623.1 | 621.8 |
- 年度
- 每季度
2021 | 2020 | 2019 | 2018 | 2017 | |
---|---|---|---|---|---|
净收入/起跑线 | 1503.1 | 823.4 | 1046.9 | 722.2 | 583.6 |
经营活动产生的现金 | 1732.1 | 1054.3 | 1179.4 | 926.8 | 1000.7 |
经营活动产生的现金 | 134.8 | 107.2 | 89.3 | 77.4 | 81.9 |
Deferred Taxes | -41.4 | -49.4 | 12.1 | -27.3 | 17.8 |
非现金物品 | -9.7 | 130.9 | 235.4 | 197.1 | 83.2 |
Cash Taxes Paid | 182.5 | 197.9 | 61.5 | 223.7 | 143.7 |
已付现金利息 | 20.2 | 19.9 | 19.9 | 30.1 | 19.9 |
营运资金的变化 | 145.3 | 42.2 | -204.3 | -42.6 | 234.2 |
投资活动产生的现金 | -1722.5 | -531.1 | -595.8 | 76.7 | -647.2 |
资本支出 | -329.8 | -407.3 | -278.4 | -241.7 | -175.5 |
其他投资现金流量项目,总计 | -1392.7 | -123.8 | -317.4 | 318.4 | -471.7 |
融资活动产生的现金 | -356.3 | -486.9 | -115.6 | -1101.2 | -473.2 |
融资现金流项目 | -0.3 | -1.2 | -2.8 | -15.4 | 0 |
股票的发行(报废),净额 | -354.2 | -484.9 | -102.8 | -648.5 | -649.5 |
债务的发行(退还),净额 | -1.8 | -0.8 | -10 | -437.3 | 176.3 |
外汇效应 | 13.9 | -20.5 | -3 | -6.5 | 7.9 |
现金净变化 | -332.8 | 15.8 | 465 | -104.2 | -111.8 |
Mar 2022 | Dec 2021 | Sep 2021 | Jun 2021 | Mar 2021 | |
---|---|---|---|---|---|
Net income/Starting Line | 373.6 | 1503.1 | 1167.8 | 827.7 | 338.2 |
Cash From Operating Activities | 293.3 | 1732.1 | 1358.5 | 826.6 | 300.5 |
Cash From Operating Activities | 34.7 | 134.8 | 101.8 | 68.2 | 32.4 |
Deferred Taxes | -42.6 | -41.4 | 20.1 | 16.2 | 10.8 |
Non-Cash Items | 57 | -9.7 | -15.8 | -47.5 | 28.3 |
Changes in Working Capital | -129.4 | 145.3 | 84.6 | -38 | -109.2 |
Cash From Investing Activities | 229.5 | -1722.5 | -756.6 | -379.2 | -49.7 |
Capital Expenditures | -72.7 | -329.8 | -236 | -175.3 | -106 |
Other Investing Cash Flow Items, Total | 302.2 | -1392.7 | -520.6 | -203.9 | 56.3 |
Cash From Financing Activities | -368.1 | -356.3 | -294.3 | -333.3 | -274.3 |
Financing Cash Flow Items | 0 | -0.3 | -1 | -3 | -2.9 |
Issuance (Retirement) of Stock, Net | -368.1 | -354.2 | -291.6 | -328.7 | -271 |
Issuance (Retirement) of Debt, Net | 0 | -1.8 | -1.7 | -1.6 | -0.4 |
Foreign Exchange Effects | 13.2 | 13.9 | 12.1 | 11.6 | 14.2 |
Net Change in Cash | 167.9 | -332.8 | 319.7 | 125.7 | -9.3 |
投资者名称 | 投资者类型 | 流通股百分比 | 持有股份 | 股份变动 | 持有日期 | 换手率 |
---|---|---|---|---|---|---|
The Vanguard Group, Inc. | Investment Advisor/Hedge Fund | 8.4282 | 51269903 | 639997 | 2022-12-31 | LOW |
BlackRock Institutional Trust Company, N.A. | Investment Advisor | 5.3695 | 32663343 | 1051645 | 2022-12-31 | LOW |
State Street Global Advisors (US) | Investment Advisor/Hedge Fund | 4.488 | 27301166 | 493844 | 2022-12-31 | LOW |
Capital International Investors | Investment Advisor | 3.7385 | 22741986 | 44526 | 2022-12-31 | LOW |
AllianceBernstein L.P. | Investment Advisor/Hedge Fund | 3.6146 | 21988324 | 4770672 | 2022-12-31 | LOW |
Wellington Management Company, LLP | Investment Advisor/Hedge Fund | 2.5105 | 15271736 | 624619 | 2022-12-31 | LOW |
Brown Advisory | Investment Advisor/Hedge Fund | 2.3575 | 14341102 | 115268 | 2022-12-31 | LOW |
Geode Capital Management, L.L.C. | Investment Advisor/Hedge Fund | 1.9951 | 12136243 | 205714 | 2022-12-31 | LOW |
Walter Scott & Partners Ltd. | Investment Advisor/Hedge Fund | 1.811 | 11016774 | -647534 | 2022-12-31 | LOW |
Norges Bank Investment Management (NBIM) | Sovereign Wealth Fund | 1.4506 | 8824423 | 2342600 | 2022-12-31 | LOW |
Fisher Investments | Investment Advisor/Hedge Fund | 1.2613 | 7672618 | 133880 | 2022-12-31 | LOW |
Sands Capital Management, LLC | Investment Advisor | 1.2356 | 7516085 | -2889817 | 2022-12-31 | LOW |
Two Sigma Investments, LP | Hedge Fund | 1.0808 | 6574509 | 4084454 | 2022-12-31 | HIGH |
BlackRock Asset Management Ireland Limited | Investment Advisor | 0.9468 | 5759351 | 129517 | 2022-12-31 | LOW |
Nuveen LLC | Pension Fund | 0.8833 | 5373020 | -65227 | 2022-12-31 | LOW |
BlackRock Investment Management (UK) Ltd. | Investment Advisor/Hedge Fund | 0.7864 | 4783540 | -652308 | 2022-12-31 | LOW |
Millennium Management LLC | Hedge Fund | 0.7454 | 4534155 | 2227180 | 2022-12-31 | HIGH |
Legal & General Investment Management Ltd. | Investment Advisor/Hedge Fund | 0.7446 | 4529198 | -237259 | 2022-12-31 | LOW |
Northern Trust Investments, Inc. | Investment Advisor/Hedge Fund | 0.7156 | 4353305 | 8792 | 2022-12-31 | LOW |
American Century Investment Management, Inc. | Investment Advisor/Hedge Fund | 0.7115 | 4328367 | 473547 | 2022-12-31 | LOW |
交易計算器
如果您在特定日期(选择一个日期)开立差价合约交易并在不同日期(选择一个日期)关闭交易,计算您的假设盈亏。
貿易佣金
0
- 1:1
杠杆
1:1
- 20
- 100
- 500
- 1000
- 10000
投資
交易規模(槓桿 x 投資):
開倉
平倉
做空 做多
Edwards Lifesciences Company profile
关于 Edwards Lifesciences
Edwards Lifesciences公司是一家心脏瓣膜系统和修复产品的制造商,用于替换或修复病人患病或有缺陷的心脏瓣膜。 该公司从事以病人为中心的结构性心脏病和重症监护的创新工作。 它的分部包括美国、欧洲、日本和世界其他地区。 其产品和技术分为四个主要领域。 经导管主动脉瓣置换术、经导管二尖瓣和三尖瓣治疗术、外科结构性心脏病和重症监护。 该公司还开发了血液动力学和无创的脑和组织氧饱和度监测系统,用于在医院环境中测量病人的心血管功能。 Edwards SAPIEN系列瓣膜,包括Edwards SAPIEN XT、Edwards SAPIEN 3和Edwards SAPIEN 3 Ultra经导管主动脉心脏瓣膜,用于治疗心脏瓣膜疾病。
Industry: | Advanced Medical Equipment & Technology (NEC) |
One Edwards Way
92614
收入报表
- Annual
- Quarterly
人们也观看
还在找一位您可以信任的经纪商吗?
加入成为全球500,000万多名交易者的一份子,选择利用Capital.com进行交易吧。